Treating Challenging or Dangerous Behaviors, Part 1: Medical Support

This webinar took place on April 29, 2021
A discussion regarding pharmaceutical and other medical interventions that address severe and dangerous behaviors in children, adolescents and adults with severe forms of autism.
Featuring:
Carmen Lopez-Arvizu, MD, Child and Adolescent Psychiatrist, Kennedy Krieger Institute
Lee Elizabeth Wachtel, MD, Director, Neurobehavioral Unit, Kennedy Krieger Institute
Robert Hendren, DO, Professor of Psychiatry and Behavioral Science, UCSF

Access the video recording here (via Zoom)
Access the video recording, via NCSA YouTube channel, here
Access Dr. Hendren’s slides here
Access Dr. Lopez-Arvizu’s slides here

Erratum: On Dr Lopez’s slides:
Zonegran (not Zonegram) is zonisamide.
Keppra is levetiracetam.
The slide had indicated that zonegram = keppra, which is incorrect.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website and related sites, such as our NCSA YouTube channel, are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.